Menu

Blog

Page 28

Feb 22, 2024

Microsoft and Intel strike a custom chip deal that could be worth billions

Posted by in categories: business, computing

Microsoft is a big win for Intel’s chip foundry business.

Feb 22, 2024

Tesla dealership building in Golden Valley sells for $23.7M

Posted by in category: habitats

Drake Motor Partners developed the dealership last year and now sold it for $23.7 million.

Feb 22, 2024

Intel signs Microsoft as foundry customer, says on track to overtake TSMC

Posted by in category: computing

Intel said on Wednesday that Microsoft plans to use its services to manufacture a custom computing chip and that the company expects to beat an internal deadline of 2025 to overtake its biggest rival, Taiwan Semiconductor Manufacturing Co, in advanced chip manufacturing.

Feb 22, 2024

Researchers measure speed of sound in the quark–gluon plasma more precisely than ever before

Posted by in categories: particle physics, space

Neutron stars in the universe, ultracold atomic gases in the laboratory, and the quark–gluon plasma created in collisions of atomic nuclei at the Large Hadron Collider (LHC): they may seem totally unrelated but, surprisingly enough, they have something in common.

They are all a fluid-like state of matter made up of strongly interacting particles. Insights into the properties and behavior of any of these almost-perfect liquids may be key to understanding nature across scales that are orders of magnitude apart.

In a new paper, the CMS collaboration reports the most precise measurement to date of the speed at which sound travels in the quark–gluon plasma, offering new insights into this extremely hot state of matter.

Feb 22, 2024

In deep reinforcement learning, a pruned network is a good network

Posted by in category: futurism

Join the discussion on this paper page.

Feb 22, 2024

Finding the Right Targets to Treat Biliary Tract Cancers

Posted by in categories: biotech/medical, satellites

Researchers are working on ways to improve the effectiveness of currently approved bile duct cancer, also called cholangiocarcinoma, treatments and finding early success in the development of more targeted therapies. Read more on the AACR Blog:


To overcome this issue, researchers are exploring next-generation FGFR inhibitors. During the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in January 2024, phase II clinical trial results were announced for tinengotinib, a FGFR1-3 inhibitor that binds to FGFR in a way that blocks FGFR2 fusion and rearrangement, preventing the mutations that cause resistance to treatment. Of the patients in the trial whose tumors had developed resistance to a previous FGFR inhibitor, 37.5% demonstrated a partial response with tumor reductions ranging from 40.7% to 54.6%. A phase III trial for the drug candidate kicked off in December 2023.

Other next-generation FGFR inhibitors are in various stages of development, including RLY-4008 (phase I/II trial), erdafitinib (phase IIa), KIN-3248 (phase I/Ib), derazantinib (phase II), tasurgratinib (phase II), and HMPL-453 (phase II).

Continue reading “Finding the Right Targets to Treat Biliary Tract Cancers” »

Feb 22, 2024

A light touch: Changing the way we treat traumatic brain injury

Posted by in categories: biotech/medical, health, neuroscience

Contrary to popular perception, traumatic brain injury (TBI) is not the reserve of car accidents and punishing contact sports; it’s surprisingly common. Up to 50 million new cases of traumatic brain injury are registered each year worldwide. Notably, 80% of TBI occurs in low-to middle-income countries, and it is also the leading cause of death and disability in young adults. Overall, the global economic burden of TBI is estimated at 400 billion USD.

Minimising the devastating effects of TBI doesn’t rely solely on reducing the risk of an injury; it’s also essential to improve treatment after one has happened. For that, physiological real-time monitoring of vital signals is critical. One inventor has made it his mission to create devices that can do this accurately, easily, anywhere, and what’s more, they are also non-invasive.

Professor Arminas Ragauskas is a founder and director of the Health Telematics Science Institute at Kaunas University of Technology in Lithuania, which develops innovative industrial and physiological measurement and process monitoring technologies. He is particularly known for his work on non-invasive intracranial pressure and cerebral blood flow autoregulation measurement devices. He was also the national coordinator of the CENTER-TBI project, funded by the European Commission and the EU industry, with a budget of 40 million EUR, and focused European efforts to advance the care of patients with traumatic brain injury.

Feb 22, 2024

Universe’s brightest known object and fastest-growing black hole revealed

Posted by in category: cosmology

The universe’s brightest object is a quasar in a distant galaxy that’s powered by the fastest-growing black hole ever recorded, according to a new study.

Feb 22, 2024

Googol Gear #shorts

Posted by in category: futurism

#facts #uniquefacts #science #experiment

Feb 21, 2024

LongRoPE: Extending LLM Context Window Beyond 2 Million Tokens

Posted by in category: futurism

Microsoft presents LongRoPE

Extending LLM context window beyond 2 million tokens.


Join the discussion on this paper page.

Page 28 of 10,658First2526272829303132Last